2018 Corporate Excellence Awards Supplement
138 CORPORATE VISION / Corporate Excellence Awards 2018 CORPORATE VISION / Issue 7 2018 43 , Committed to providing innovative cancer care, Proton Partners International is a thriving healthcare companymaking great strides in the health sector. We profile the organisation to discover more about their innovative ways and what the future holds for the company. Proton Beam Therapy Proton Partners International was formed to respond to the growing global demand for high energy proton beam therapy. The founders had a very clear vision; to build a network of cancer centres in the UK and in international markets. The team has now raised over £120m in equity and £30m in debt to build out the first five proton beam therapy centres named The Rutherford Cancer Centres. Early equity investors included Woodford Funds and the Wales Life Sciences Investment Fund. £30m of the debt provision was put in place by Shawbrook Bank which, at the time, was the largest debt provision in the Bank’s history. Taking a look into the internal culture of Proton Partners, the team has been recruited with a strategy in mind, with all staff members working towards the same mission, ensuring a thriving work environment. Everyone within the company takes tremendous pride in what it is achieving, collaborating to build an impressive network of oncology centres. Mike started out with the ambition of building a company with Excellence in mind. To achieve this, the firm developed an Excellence Model which had four pillars, with each pillar supported by a number of strategic actions. The four pillars are; Operational and Clinical Excellence, the Patient Experience, Improving Cancer Care and, Advancing proton beam therapy Technology. The two central pillars are about the patient and everything else that staff do supports them. With these exciting projects ahead, there is clearly a lot to look forwards to for Proton Partners. However, as with any industry, there will always 1805CV26 be some challenges that the company will have to overcome. This does not worry the team as they will embrace these issues and look for solutions to overcome them. Mike explains what the future holds for Proton Partners, alluding to the two building projects that the company is undertaking, as well as its new partnerships. Ultimately, as the world moves forward and technology becomes more advanced, the market for proton beam therapy is rapidly evolving, and Proton Partners International will be at the forefront of the growth and will continue to invest, in centres and innovation, to maintain its position as market leaders. Company: Proton Partners International Limited Contact: Mike Moran Address: 3 Assembly Square, Cardiff, CF10 4PL, UK Phone: 2077100020 Website: www.proton-int.com
Made with FlippingBook
RkJQdWJsaXNoZXIy NTY1MjI4